MGH, ElevateBio sign 10-year deal to develop cancer cell therapies
July 25, 2019 at 07:00 AM EDT
Massachusetts General Hospital and its parent organization may be making several changes, but one part of its future is clear: A decade-long collaboration with an emerging cell and gene therapy investor.
